Clinical Trials Logo

Rectal Bleeding clinical trials

View clinical trials related to Rectal Bleeding.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05043363 Completed - Bowel Cancer Clinical Trials

LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19

LuCID
Start date: November 14, 2020
Phase:
Study type: Observational

The LumenEye scope and CHiP platform will be piloted in a number of clinical settings including remote colorectal clinics. The rationale is to perform an initial pilot study to determine the clinical utility of the LumenEye device for use in primary and secondary care settings. The main hypothesis is that digital rectoscopy is safe and acceptable to clinicians including general practitioners and can significantly reduce the burden of endoscopy referral to and within secondary care centres.

NCT ID: NCT02303756 Completed - Rectal Bleeding Clinical Trials

Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's A Pilot Study

Start date: August 2015
Phase: N/A
Study type: Interventional

The primary aim is to evaluate the efficiency of capsule endoscopy (CCE) in in the detection of neoplasms compared to conventional colonoscopy in persons participating in the Danish screening program for colorectal cancer with a positive fecal occult blood with the colonoscopy being the gold standard.

NCT ID: NCT02104271 Completed - Radiation Injuries Clinical Trials

Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.

Start date: January 2013
Phase: Phase 2
Study type: Interventional

There is a wide variability of options for treatment of chronic radiation proctitis. However, studies are still limited, usually case reports from a single center and few are comparative studies between methods. Therefore, the choice of treatment is determined by availability and local expertise for each method. The variability of treatment options range from anti-inflammatory medical treatment, sucralfate, short chain fatty acids, antioxidants and hyperbaric oxygen to such endoscopic and surgical treatments. Surgery is usually the last therapeutic option due to the high morbidity and mortalityassociated. Various endoscopic treatment modalities have been reported. Formalin topic is effective in up to 48% of patients with chronic radiation proctitis. The endoscopic treatment with argon plasma (APC) is low cost, easy to apply and transportation, safe and effective in the treatment of rectal bleeding in patients with chronic radiation proctitis. Currently, the APC is the preferred endoscopic modality. Most studies on the use of APC in radiation proctitis showed benefit. The APC controls the mild to moderate rectal bleeding in 80% to 90% of cases and improves symptoms of urgency, diarrhea and tenesmus in 60% to 75% of cases.

NCT ID: NCT01727388 Completed - Colon Cancer Clinical Trials

Informativeness to Digital Rectal Examination

RIFIONA
Start date: November 2012
Phase: Phase 3
Study type: Interventional

Digital rectal examination is an act clinically performed daily by physicians and surgeons. It remains the key diagnostic test and directs the therapeutic management of cancer of the lower and middle rectum. It can be done in two main positions: lateral decubitus, and supine. However, no randomized study in colorectal surgery is not interested in evaluating the best position to perform a full rectal exam.

NCT ID: NCT01623206 Completed - Colorectal Cancer Clinical Trials

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Start date: April 2013
Phase: Phase 2
Study type: Interventional

The objective of this study is to find the maximum tolerated dose and preliminary efficacy of desmopressin as an haemostatic agent, when is administered to patients with colorectal cancer and rectal bleeding, before specific oncologic treatment with surgery and/or chemotherapy and/or radiotherapy.